Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Onartuzumab
Trade Name
Synonyms MetMAb|RO5490258|OA-5D5
Drug Descriptions

Onartuzumab is a monovalent antibody that binds MET and inhibits MET/HGF signaling, potentially resulting in decreased tumor growth (PMID: 23882082, PMID: 30472556).

DrugClasses MET Antibody 22
CAS Registry Number 1133766-06-9
NCIT ID C82348


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Carboplatin + Erlotinib + Onartuzumab + Paclitaxel Carboplatin Erlotinib Onartuzumab Paclitaxel 0 1
Carboplatin + Onartuzumab + Paclitaxel Carboplatin Onartuzumab Paclitaxel 0 1
Cobimetinib + Onartuzumab Cobimetinib Onartuzumab 0 1
Cobimetinib + Onartuzumab + Vemurafenib Cobimetinib Onartuzumab Vemurafenib 0 1
Erlotinib + Onartuzumab Erlotinib Onartuzumab 0 1
Fluorouracil + Leucovorin + Onartuzumab + Oxaliplatin Fluorouracil Leucovorin Onartuzumab Oxaliplatin 0 0
Onartuzumab Onartuzumab 0 2
Onartuzumab + Vemurafenib Onartuzumab Vemurafenib 0 1

Additional content available in CKB BOOST